Navigation Links
CyberKnife Cancer Institute of Chicago Is the First to Offer CyberKnife Treatment in the City of Chicago
Date:8/30/2012

CHICAGO, Aug. 30, 2012 /PRNewswire/ -- CyberKnife Cancer Institute of Chicago, a program of Swedish Covenant Hospital, is the first and only center within the City of Chicago to offer the revolutionary CyberKnife stereotactic radiosurgery treatment. The 10,000 sq. ft. state-of-the-art facility is treating patients with cancers of the brain, spine, pancreas, prostate, kidney, liver and lung. The technology is also effective for certain nervous system conditions like trigeminal neuralgia and arteriovenous malformations. The center is supported throughout the Chicagoland area by 24 credentialed physicians as well as a partnership with Radiology Oncology, S.C., a division of Alpha Med Physicians Group.

(Logo:  http://photos.prnewswire.com/prnh/20120830/CG65933LOGO)

As a non-invasive alternative to surgery, CyberKnife Robotic Radiosurgery can effectively treat complex tumors located virtually anywhere in the body. These treatments offer a reduced the risk of complications, allow the treatment of recurrent tumors, and are comfortable procedures that can usually be completed in around an hour per treatment.

"We are thrilled to have CyberKnife technology in Chicago and conveniently on Chicago's Magnificent Mile. It grants us the opportunity to treat patients with the most revolutionary tumor technology available for a higher level of patient care and ultimately treatment success," says Dr. Adam Dickler, Medical Director of the CyberKnife Cancer Institute of Chicago.

To learn more about CyberKnife and locate a referring physician, visit www.ckcancerchicago.com.

About CyberKnife Cancer Institute of Chicago, a program of Swedish Covenant Hospital

CyberKnife Cancer Institute of Chicago is the only center within the city of Chicago to offer the revolutionary CyberKnife stereotactic radiosurgery s
'/>"/>

SOURCE CyberKnife Cancer Institute of Chicago
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
2. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
3. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
4. Quest Diagnostics Launches Molecular Cervical Cancer Test Based on National Institutes of Healths TERC Gene Marker
5. Polymedco Aligns with MedPrimex to Fight Colorectal Cancer in Mexico
6. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
7. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
8. Breast Cancer Diagnostic and Drug Technologies: Global Markets
9. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
10. Brain Cancer Research in Seattle Leads to New Treatment Options for Patients
11. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... N.J. and INDIANAPOLIS, March 29, 2011 Oral ... the updated clinical practice guidelines as a Class ... coronary intervention (PCI) after experiencing heart-related chest pain ... myocardial infarction (NSTEMI).  NSTEMI is a type of ...
... MicroCHIPS, Inc., a developer of innovative drug delivery devices ... and Trademark Office has granted U.S. Patent No. 7,892,221, ... patent in conjunction with U.S. Patent No. 7,070,590 provides ... medical devices used for implantable drug delivery systems. ...
Cached Medicine Technology:Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 2Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 3Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 4Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 5Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 6MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems 2
(Date:4/23/2014)... frozen stool from healthy, unrelated donors was safe ... diarrhea caused by Clostridium difficile , according ... Clinical Infectious Diseases and available online. Known ... effective whether given via a colonoscope or a ... make this promising treatment more readily available to ...
(Date:4/23/2014)... looking to give exercise enthusiasts the extra nudge they ... that a cyber buddy can help. , The study, ... , is the first to indicate that although a ... a software-generated partner also can be effective. , "We ... still motivate people to give greater effort while exercising ...
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
(Date:4/23/2014)... (April 23, 2014) The American Gastroenterological Association ... 2014 AGA Research Scholars. The AGA Research Scholar ... to develop independent and productive research careers in ... Awards fund an additional year allowing for three ... to supporting junior faculty who are paving the ...
(Date:4/23/2014)... A team of scientists led by a researcher from ... the National University of Singapore has identified the cancer ... opens up the possibility of developing new drugs for ... cancers. , The research group, led by Dr Chan ... for the first time that a cancer-specific variant of ...
Breaking Medicine News(10 mins):Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... has the second most populous Jewish community in America, ... Florida for economic opportunities, for the climate, to join ... growing Jewish population of Broward County is now declining ... University of Miami professor Dr. Ira M. Sheskin, from ...
... March 10 A recent CBS 60 Minutes ... a red wine molecule believed to largely be ... French have far more people living beyond 100 ... from heart disease than other people living in ...
... , , TUESDAY, March 10 (HealthDay News) -- The chances of ... that sells alcohol to go, according to a study by ... and around off-premise alcohol outlets were shot as the victims ... were easier targets or they were shot as the victims ...
... Omega Protein Corporation (NYSE: OME ), the ... fish meal products, today reported net income of $12.6 ... December 31, 2008, compared with net income of $12.1 ... 31, 2007.(Logo: http://www.newscom.com/cgi-bin/prnh/20030516/OMEGALOGO )For the year ended ...
... LAKEWOOD, Colo., March 10 Mesa Laboratories, Inc. ... consumables for healthcare and manufacturing quality control applications, today announced ... of Chief Executive Officer (CEO), replacing Luke R. Schmieder, who ... Mr. Schmieder is retiring from Mesa and resigning his ...
... of packaging traceability posed by regulated medical wasteCLEVELAND, ... a leader in label, packaging , promotion ... placard identification reusable labeling solution to meet stringent ... containers for biomedical waste. Subject to governmental regulations, ...
Cached Medicine News:Health News:UM study reveals demographic trend of the Jewish population in Broward County 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 3Health News:Shootings Linked to Alcohol-to-Go Outlets, Study Finds 2Health News:Omega Protein Reports 2008 Results 2Health News:Omega Protein Reports 2008 Results 3Health News:Omega Protein Reports 2008 Results 4Health News:Omega Protein Reports 2008 Results 5Health News:Mesa Labs Announces the Appointment of New CEO 2Health News:Mesa Labs Announces the Appointment of New CEO 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 2Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 4
... surgical approach to glaucoma management that employs ... ciliary body (which produces aqueous humour) is ... or posterior segment, through the endoscope in ... and accurately identified utilizing endoscopy. This allows ...
... of German Craftsmanship have produced ... the world. Ocutek® now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
Medicine Products: